comparemela.com

Latest Breaking News On - Laurence de schoulepnikoff - Page 1 : comparemela.com

Strong investment continues for developer of Autoimmune Therapies

Biotech start-up Tridek-One focused on research and development of CD31 agonists to restore the immune balance, has closed a €16 million ($16. Click to read more.

France generalUnited kingdomBenoit barteauGiuseppina caligiuriPureos bioventuresKlaus breinerAdvent life sciences united kingdomAdvent life sciencesBioqube venturesAdvent lifeAntonino nicolettiLaurence de schoulepnikoff

OSE Immunotherapeutics Announces the Appointment of Dominique Costantini as Interim CEO Following the Departure of Alexis Peyroles

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Alexis peyrolesDominique costantiniNantes university hospitalBoehringer ingelheimChief executiveChief executive officerLaurence de schoulepnikoffChief business officerChief operating officerNon small cell lung cancerExpansion phaseUniversal registration documentCoronavirus pandemicOse immunotherapeutics saGlobe newswire

OSE Immunotherapeutics Strengthens Leadership Team with the Appointment of Laurence de Schoulepnikoff as Chief Business Officer

In Addition, Three Senior Executives Will Reinforce the Company’s Drug Development Engine .

Silvia comisSanofi evotecAlexis peyrolesDominique costantiniLinda lebonToulouse universityBusiness development at novartisEuropean head of early products medical affairsBoehringer ingelheimSciences aggregationPfizer animal healthCompany as head of clinical developmentFerring internationalBono as senior strategic development directorNantes university hospitalAlliance management

vimarsana © 2020. All Rights Reserved.